Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers-Letter

被引：15
|
作者：
Ferrara, Roberto [1 ,2 ]
Susini, Sandrine [3 ]
Marabelle, Aurelien [3 ,4 ]
机构：
[1] Ist Nazl Tumori, Med Oncol, Milan, Italy
[2] Gustave Roussy, LIO, Villejuif, France
[3] Univ Paris Saclay, Gustave Roussy, INSERM, U1015, Villejuif, France
[4] Univ Paris Saclay, Gustave Roussy, Dept Innovat Therapeut & Essais Precoces, Villejuif, France
来源：
CLINICAL CANCER RESEARCH | 2019年 / 25卷 / 11期
关键词：
D O I：
10.1158/1078-0432.CCR-18-3740
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3468 / 3468
页数：1
相关论文
共 50 条
  • [1] Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers
    Sharma, Anu
    Subudhi, Sumit K.
    Blando, Jorge
    Scutti, Jorge
    Vence, Luis
    Wargo, Jennifer
    Allison, James P.
    Ribas, Antoni
    Sharma, Padmanee
    CLINICAL CANCER RESEARCH, 2019, 25 (04) : 1233 - 1238
  • [2] Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers-Response
    Sharma, Anu
    Subudhi, Sumit K.
    Blando, Jorge
    Vence, Luis
    Wargo, Jennifer
    Allison, James P.
    Ribas, Antoni
    Sharma, Padmanee
    CLINICAL CANCER RESEARCH, 2019, 25 (11) : 3469 - 3470
  • [3] CTLA-4 targeted engineered toxin bodies designed to deplete regulatory T cells (Tregs)
    Iberg, Aimee
    Acquaye-Seedah, Edith
    Rabia, Lilia A.
    Robinson, Garrett L.
    Ramos, Hilario J.
    Dekker, Joseph D.
    Zhao, Jay
    Willert, Erin K.
    CANCER RESEARCH, 2020, 80 (16)
  • [4] FOXP3+ regulatory T cells in the human immune system
    Shimon Sakaguchi
    Makoto Miyara
    Cristina M. Costantino
    David A. Hafler
    Nature Reviews Immunology, 2010, 10 : 490 - 500
  • [5] FOXP3+ regulatory T cells in the human immune system
    Sakaguchi, Shimon
    Miyara, Makoto
    Costantino, Cristina M.
    Hafler, David A.
    NATURE REVIEWS IMMUNOLOGY, 2010, 10 (07) : 490 - 500
  • [6] FOXP3+ regulatory T cells as biomarkers in human malignancies
    Bignone, Paola A.
    Banham, Alison H.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (12) : 1897 - 1920
  • [7] Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade?
    Fei Tang
    Xuexiang Du
    Mingyue Liu
    Pan Zheng
    Yang Liu
    Cell & Bioscience, 8
  • [8] Transcriptome profiling of human FoxP3+ regulatory T cells
    Bhairavabhotla, Ravikiran
    Kim, Yong C.
    Glass, Deborah D.
    Escobar, Thelma M.
    Patel, Mira C.
    Zahr, Rami
    Nguyen, Cuong K.
    Kilaru, Gokhul K.
    Muljo, Stefan A.
    Shevach, Ethan M.
    HUMAN IMMUNOLOGY, 2016, 77 (02) : 201 - 213
  • [9] Anti-CTLA-4 antibodies in cancer immunotherapy: selective depletion of intratumoral regulatory T cells or checkpoint blockade?
    Tang, Fei
    Du, Xuexiang
    Liu, Mingyue
    Zheng, Pan
    Liu, Yang
    CELL AND BIOSCIENCE, 2018, 8
  • [10] CTLA-4 control over Foxp3+ regulatory T cell function
    Wing, Kajsa
    Onishi, Yasushi
    Prieto-Martin, Paz
    Yamaguchi, Tomoyuki
    Miyara, Makoto
    Fehervari, Zoltan
    Nomura, Takashi
    Sakaguchi, Shimon
    SCIENCE, 2008, 322 (5899) : 271 - 275
12345